Genocea Biosciences shares rocket 101% after biotech announces positive data from early-stage trial of cancer vaccine

Indonesia Berita Berita

Genocea Biosciences shares rocket 101% after biotech announces positive data from early-stage trial of cancer vaccine
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

Genocea Biosciences shares rocket 101% after positive data on cancer vaccine

Shares of Genocea Biosciences Inc.

surged 101% in premarket trade Monday after the biotech announced promising data from an early-stage clinical trial of its lead drug candidate, a personalized cancer vaccine. Genocea's vaccine, called GEN-009, uses neoantigens -- antigens corresponding to tumor mutations that a patient's immune system sees as foreign to the body -- to prime the immune system to find and kill tumors.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

MarketWatch /  🏆 3. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

The next stage of Rocket InternetThe next stage of Rocket InternetFive years after going public, analysts think Europe’s startup factory should take itself private
Baca lebih lajut »

Measles 2019: Three charts show decades of vaccines' successes at riskMeasles 2019: Three charts show decades of vaccines' successes at risk
Baca lebih lajut »

The measles infected nearly every child in the US — until the vaccine was introducedThe measles infected nearly every child in the US — until the vaccine was introducedMeasles infected almost every American child until the vaccine eliminated the disease from the US. Now some parents are refusing to vaccinate their children, threatening to allow measles to make a comeback.
Baca lebih lajut »

How the anti-vaccine movement crept into the GOP mainstreamHow the anti-vaccine movement crept into the GOP mainstreamThe anti-vaccine movement has grown into a political rebellion that is drawing in state Republican officials who distrust government medical mandates
Baca lebih lajut »

College Rocket-Builders Are Flying High, Even as Launch Falls a Bit ShortCollege Rocket-Builders Are Flying High, Even as Launch Falls a Bit ShortOperation Space—made up of college students who hadn’t met—got together in New Mexico over the weekend to launch rockets on which they collaborated. While the results were mixed, the students were thrilled.
Baca lebih lajut »

A glimpse into the space rocket warsA glimpse into the space rocket warsNorthrop Grumman’s OmegA space is among a trio of competitors for the Air Force’s next-generation space launch system.
Baca lebih lajut »

Kremlin's space agency condemns Pentagon plans to ban Russian rockets over 'unacceptable cybersecurity risk'Kremlin's space agency condemns Pentagon plans to ban Russian rockets over 'unacceptable cybersecurity risk'Roscosmos says the U.S. wants to “destroy” Russian-American relations in space.
Baca lebih lajut »

Democrats Make It Tougher For Candidates To Reach Debate StageDemocrats Make It Tougher For Candidates To Reach Debate StageDemocrats are making it tougher for candidates to reach the debate stage
Baca lebih lajut »



Render Time: 2025-03-13 12:27:26